Animal Welfare in Zoonotic Disease Research

Research on zoonotic diseases -- those that cross from animals to humans -- involves significant numbers of wild-caught and laboratory animals, with welfare implications that vary by research context and method.

Key Facts

COVID-19 research used millions of laboratory animals including mice, ferrets, and hamsters
Wild-caught animals used in zoonotic research face transport stress and acute capture trauma before laboratory work begins
Some zoonotic research can use non-lethal sampling methods that significantly reduce welfare harm
Biosafety requirements for zoonotic research create additional constraints on animal housing and enrichment
The 3Rs framework applies to zoonotic disease research but implementation varies significantly by jurisdiction

Welfare Considerations

Zoonotic disease research welfare involves genuine tensions between the urgency of human health protection and the welfare of research animals. The COVID-19 pandemic accelerated animal research on a scale that compressed the timeline for welfare review. Animals in high-level biosafety facilities face restrictions on enrichment and social housing that would not be acceptable in standard research contexts -- the biosafety requirements that protect researchers impose welfare costs on animals. Applying 3Rs principles rigorously in pandemic preparedness research -- replacing animals where possible, reducing numbers through better experimental design, refining procedures to reduce suffering -- is essential for maintaining welfare standards even under urgency pressure.

What You Can Do

Support funding for non-animal zoonotic disease research alternatives
Advocate for 3Rs application in pandemic preparedness research frameworks
Engage with the ethical complexity of urgent human health research that involves animal welfare costs
Support wildlife surveillance methods that use non-lethal sampling to reduce welfare harm